PHOENIX, Ariz. and VANCOUVER, B.C., Aug. 23, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company with a focus on sublingual drug delivery, is pleased to announce CEO Dr. Hassan Salari was interviewed recently by Ms. Jennifer Lazorack for PremierStocks.tv. Dr. Salari and Ms.Lazorack discussed that the company has completed a large clinical study of the company's Sublingual Drug Delivery System X-Excite along with the company's commercialization strategy and the management appointment of Dr. Lola Maksumova, MD, Ph.D., as Senior Vice President and Chief Operating Officer.
Dr. Hassan Salari, Ph.D, CEO expressed, "We were pleased to be interviewed by the PremierStocks.tv staff and are excited to have a platform for review by the investment community. The video interview allows us to go into more detail about our goals to commercialize our sublingual drug delivery system."
Kelly Black, President of Premier Media Services Inc., stated, "With millions of Americans suffering from major side-effects from their prescription medications, GHLV offers a new and effective way to deliver medicine that will bypass the digestive system and reduce the side-effects of many medications. I think that the advantages of sublingual drug delivery will be a benefit to the medical healthcare system and bring relief quickly to patients."
To see the entire interview with Hassan Salari, CEO and President of Global Health Ventures Inc.: http://youtu.be/VaL8Q9CNXPg
For a current corporate fact sheet http://www.premierstocks.tv/images/company_links/GHLVlogo.pdf
About Sublingual Technology
The Company's drug formulation is designed to enhance the delivery of medical products faster to the body than current oral formulations. This design enables the vast majority of pharmaceutical drugs to be rapidly absorbed through the mucosal membrane (tissues of the mouth) quickly. This technology works well for drugs that need faster results and have major side-effects associated with gastrointestinal and/or liver break down. It is scientifically accepted that the sublingual drug delivery route is the fastest and most efficient way of drug delivery after direct injection.
About Global Health Ventures (OTCBB:GHLV)
Global Health Ventures is a specialty pharmaceutical company with expertise in drug delivery and formulation. The Company has developed a new formulation for drug delivery via the sublingual (under the tongue) route. This unique method delivers drugs to the bloodstream quickly with less drug breakdown in the liver or gastrointestinal system, a process that can reduce side-effects associated with the drugs. The Company's lead therapeutic product is a male sexual enhancement drug that is delivered via sublingual route and is called X-Excite. In human studies, X-Excite has been shown to reach the bloodstream faster than the oral route of delivery. The company has initiated the development of non steroidal anti inflammatory drugs (NSAIDs). Several NSAIDs have been demonstrated to carry gastrointestinal side-effects which prevent patients from using them effectively. The Company also has the drug "Relax-B," which is under development in Canada for anxiety. And, the next drug will be an anti-migraine drug. The Company plans to use the same technology to deliver a vast number of other FDA approved drugs that require faster delivery, or reduced hepatic and gastrointestinal side effects. These include anti-stress, sleeping disorders, pain killers, anti-allergy medications, heart and lung medication, migraine and addiction replacement therapies.
About Premier Media Services, Inc.
Premier Media Services, Inc. (PMSI) is a full-service public relations consulting firm dedicated to providing broadcast news and financial marketing services. PMSI offers multi-faceted public and investor relations campaigns designed to maximize institutional and private investor awareness of companies traded on all major exchanges.PMSI produces a bi-monthly broadcast news show, as well as produces live CEO Interviews, conference filming, television commercials and other broadcast services through its wholly-owned subsidiary, Premier Stocks TV (PSTV) (www.PremierStocks.tv).
Notice Regarding Forward-Looking Statements -This press release includes forward-looking statements that involve a number of risks and uncertainties, including the success of the products in commercializing and developing. Further, the risks involve the ability of the Company to raise capital to fund its operations and the capital requirements for the development and marketing of its products. Investors are encouraged to review the risk factors listed or described from time to time in the Company's filings (10K) with the Securities and Exchange Commission.